Hidden HIV in brain immune cells

Defining the HIV reservoir and latency mechanism in human brain myeloid cells

['FUNDING_R01'] · UNIV OF NORTH CAROLINA CHAPEL HILL · NIH-11309994

This project looks at whether HIV can hide and remain dormant in certain immune cells in the brains of people living with HIV who are on antiretroviral therapy.

Quick facts

Phase['FUNDING_R01']
Study typeNih_funding
SexAll
SponsorUNIV OF NORTH CAROLINA CHAPEL HILL (nih funded)
Locations1 site (CHAPEL HILL, UNITED STATES)
Trial IDNIH-11309994 on ClinicalTrials.gov

What this research studies

Researchers will work with people who donate their bodies through the Last Gift program so lab teams can isolate brain myeloid cells and grow them for study. They will try to recover and sequence any HIV from those cells, test whether the recovered virus can infect other cells, and check which genes help infected brain cells survive. The team will compare these human-derived findings with animal and cell models to build a more realistic picture of HIV persistence in the central nervous system.

Who could benefit from this research

Good fit: Ideal candidates are people living with HIV on antiretroviral therapy who are willing to participate in an end-of-life donation program like the Last Gift and coordinate with the study team at UNC Chapel Hill.

Not a fit: People who do not have HIV or who are not enrolled in the Last Gift/end-of-life donation program would not directly participate or benefit from this specific project.

Why it matters

Potential benefit: If successful, this work could point to new ways to target HIV that hides in the brain and help guide cure-directed treatments for people living with HIV.

How similar studies have performed: Animal and laboratory cell models have suggested brain reservoirs of HIV, but human-based studies are rare and this human brain cell approach is relatively new.

Where this research is happening

CHAPEL HILL, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.